Accessibility Menu
Sintx Technologies logo

Sintx Technologies(NASDAQ) SINT

Current Price$1.46
Market Cap$8.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year-49%
1 Month-29%
Sintx Technologies last closing stock price
MetricPriceDate
Last closeUSD 1.402026-07-24
Sintx Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.95%USD 1.592026-07-17
1 month-28.57%USD 1.962026-06-24
3 month-43.32%USD 2.472026-04-24
Year to date-63.73%USD 3.862025-12-31
1 year-48.53%USD 2.722025-07-24
3 year-99.57%USD 322.002023-07-25
5 year-100%USD 32,000.002021-07-23
Since inception-100%USD 610,752,688.172014-02-14

Sintx Technologies Financials at a Glance

Market Cap

$8.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.03M

Net Income (TTM)

-$17.61M

EPS (TTM)

-$5.64

P/E Ratio

-0.25

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Price

$1.46

Volume

303

Open

$1.46

Previous Close

$1.46

Daily Range

$1.46 - $1.46

52-Week Range

$1.40 - $6.78

Estimated Earnings Date

Aug 13, 2026

SINT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sintx Technologies

Sintx makes advanced ceramic materials for medical and industrial uses. Its products help doctors repair bones and fight infections. Hospitals and manufacturers use these materials for safer, stronger devices.

Products and Services

  • Medical Implants: Spinal fusion devices and foot/ankle wedges for bone repair (majority of product revenue).
  • Silicon Nitride Materials: Solid, porous, and powdered ceramics for bone growth and infection resistance.
  • Antipathogenic Solutions: Powders and coatings for masks, wound care, and medical surfaces.
  • Industrial Components: Advanced ceramics for aerospace and electrical equipment manufacturers.
  • Composites for 3D Printing: Silicon nitride mixed with polymers for custom medical devices.

Growth and Expansion

  • Acquired Sinaptic Surgical in July 2025 to expand foot and ankle offerings.
  • Sold TA&T subsidiary in February 2025 to focus on core medical business.
  • Exited armor manufacturing in August 2024, subleasing facility in October 2025 for cost savings.
  • Secured exclusive manufacturing agreement with CTL Amedica for spinal fusion products through 2028.
  • Launched SiNAPTIC foot and ankle system after FDA clearance in October 2025.

What Makes Sintx Stand Out

Sintx is the only FDA-registered maker of silicon nitride medical devices. Its ceramics combine bone growth support with infection resistance, rare in the industry. The company controls its manufacturing and holds a broad patent portfolio.

Five Things You Need to Know

  • Revenue was $1.018 million in 2025, down 65% from 2024.
  • Gross profit fell 78% to $461,000 in 2025.
  • Net loss improved to $10.4 million in 2025, from $11.0 million in 2024.
  • Five customers made up 72% of 2025 revenue.
  • Cash was $4.1 million at year-end 2025, with ongoing funding needs.

Bottom Line

Sintx has shifted focus to higher-margin medical devices and exited non-core businesses. The company faces financial challenges but continues to develop specialized ceramic solutions for healthcare and industry.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

32

CEO

Eric Kenneth Olson

Website

www.sintx.com

Headquarters

Salt Lake City, UT 84119, US

SINT Financials

Key Financial Metrics (TTM)

Gross Margin

-32.65%

Operating Margin

-1121.96%

Net Income Margin

-1711.56%

Return on Equity

-592.55%

Return on Capital

-173.54%

Return on Assets

-225.48%

Earnings Yield

-4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.36M

Volume

303

Avg. Volume

50.94K

Financials (TTM)

Gross Profit

-$336.00K

Operating Income

-$11.55M

EBITDA

-$10.23M

Operating Cash Flow

-$9.76M

Capital Expenditure

-$133.00K

Free Cash Flow

-$9.89M

Cash & ST Invst.

$1.89M

Total Debt

$3.26M

Sintx Technologies Performance Analysis

Sintx Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,561,000157.6%
20232023-12-31USD 2,627,00068.3%
20242024-12-31USD 2,887,0009.9%
20252025-12-31USD 1,018,000-64.7%
Sintx Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-72.9%
Q32025-09-30108.0%
Q42025-12-3163.9%
Q12026-03-3111.4%
Sintx Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -12,161.74-98.5%
20232023-12-31USD -624.48-94.9%
20242024-12-31USD -15.19-97.6%
20252025-12-31USD -6.16-59.5%
Sintx Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3029.5%
Q32025-09-30-280.2%
Q42025-12-3185.5%
Q12026-03-31-40.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$380.00K

+3.0%

Gross Profit

-$12.00K

-109.8%

Gross Margin

-3.16%

N/A

Market Cap

$8.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$278.15K

N/A

Employees

32

N/A

Net Income

-$2.82M

-23.1%

EBITDA

-$2.65M

-27.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.89M

-70.9%

Total Debt

$3.26M

-10.3%

Accounts Receivable

$364.00K

+275.3%

Inventory

$1.39M

+228.0%

Long Term Debt

$2.74M

-13.1%

Short Term Debt

$528.00K

+7.8%

Return on Assets

-2.25%

N/A

Return on Invested Capital

-3.17%

N/A

Free Cash Flow

-$2.50M

-83.1%

Operating Cash Flow

-$2.49M

-91.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LFWDLifeward Ltd.
$7.05+0.28%
RNAZTransCode Therapeutics, Inc.
$5.93-18.21%
HSCSHeartSciences Inc.
$2.39-2.05%
PTHLPheton Holdings Ltd Class A Ordinary Shares
$0.28-5.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%
TAT&T
$24.13+0.05%

Questions About SINT

What is the current price of Sintx Technologies?

Sintx Technologies is trading at $1.46 per share.

What is the 52-week range for Sintx Technologies?

Over the past 52 weeks, Sintx Technologies has traded between $1.40 and $6.78.

How much debt does Sintx Technologies have?

As of the most recent reporting period, Sintx Technologies reported total debt of $3.26M.

How much cash does Sintx Technologies have on hand?

Sintx Technologies reported $1.89M in cash and cash equivalents in its most recent financial results.

What is Sintx Technologies’s dividend yield?

Sintx Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services